Zacharon Pharmaceuticals
San Diego
About Zacharon Pharmaceuticals
Zacharon Pharmaceuticals is leveraging unique glycobiology expertise to develop an entirely new class of human therapeutics targeting glycans. Zacharon was incorporated in 2004 and has received initial funding through NIH grants and individual investors. Series A financing was more recently provided by Avalon Ventures, a long-standing San Diego-based venture capital firm with a focus on early stage life science companies. With this strong financial backing and innovative drug development platform in place, Zacharon is developing an entirely new class of human therapeutics addressing substantial unmet needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $4.0M
- Funding stage: M&A
- Last round: Convertible Note (Apr 2012)
- Website: zacharon.com
- Phone: 858-459-9750
Industries & Categories
Biotechnology, Developer Platform, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/zacharon-pharmaceuticals-2645119 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.